Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
730 GBX | -0.54% | -3.18% | +22.79% |
May. 31 | JPMorgan Raises Bodycote PT, Maintains Neutral Rating | MT |
May. 31 | Bodycote's New CEO Takes Office | MT |
Sales 2024 * | 813M 1.03B | Sales 2025 * | 851M 1.08B | Capitalization | 1.36B 1.73B |
---|---|---|---|---|---|
Net income 2024 * | 88M 112M | Net income 2025 * | 101M 128M | EV / Sales 2024 * | 1.82 x |
Net Debt 2024 * | 116M 148M | Net Debt 2025 * | 72.83M 92.65M | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
15.3
x | P/E ratio 2025 * |
13.1
x | Employees | 4,833 |
Yield 2024 * |
3.32% | Yield 2025 * |
3.54% | Free-Float | 97.67% |
Latest transcript on Bodycote plc
1 day | -0.54% | ||
1 week | -3.18% | ||
Current month | -3.18% | ||
1 month | +4.14% | ||
3 months | +16.15% | ||
6 months | +27.40% | ||
Current year | +22.79% |
Managers | Title | Age | Since |
---|---|---|---|
Jim Fairbairn
CEO | Chief Executive Officer | 54 | Mar. 10 |
Benjamin Fidler
DFI | Director of Finance/CFO | - | 23-02-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Larmon
BRD | Director/Board Member | 71 | 16-09-12 |
Daniel Dayan
CHM | Chairman | 60 | 21-12-31 |
Kevin Boyd
BRD | Director/Board Member | 59 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 775 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 730 | -0.54% | 152,946 |
24-06-06 | 734 | 0.00% | 115,974 |
24-06-05 | 734 | -1.61% | 149,311 |
24-06-04 | 746 | -1.06% | 186,017 |
24-06-03 | 754 | 0.00% | 216,706 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.79% | 1.73B | |
+17.78% | 90.37B | |
+12.03% | 66.35B | |
+15.24% | 35.96B | |
+20.08% | 33.29B | |
+3.07% | 26.75B | |
+4.39% | 26.14B | |
-1.20% | 25.61B | |
+15.22% | 24.36B | |
+4.30% | 22.78B |
- Stock Market
- Equities
- BOY Stock